Jiangsu Lianhuan Pharmaceutical Co Ltd Net Asset Momentum
Jiangsu Lianhuan Pharmaceutical Co Ltd net asset momentum. Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) recorded a net asset momentum of 3.9% as of December 2024, with net assets of CN¥1.58 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 600513 total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Jiangsu Lianhuan Pharmaceutical Co Ltd (2000–2024)
Net asset momentum of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2000 to 2024. This chart tracks Jiangsu Lianhuan Pharmaceutical Co Ltd's year-over-year net asset growth across 25 annual reporting periods from 2000 to 2024. The most recent momentum reading is +3.9%, with net assets of CN¥1.58 Billion CNY as of December 2024. Check 600513 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Jiangsu Lianhuan Pharmaceutical Co Ltd Net Asset Momentum by Year (2000–2024)
Jiangsu Lianhuan Pharmaceutical Co Ltd net asset momentum by year from 2000 to 2024. The table below shows the complete annual net asset history for Jiangsu Lianhuan Pharmaceutical Co Ltd from 2000 to 2024, covering 25 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Jiangsu Lianhuan Pharmaceutical Co Ltd market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.58 Billion | CN¥3.02 Billion | CN¥1.44 Billion | ▲ +3.9% |
| 2023 | CN¥1.52 Billion | CN¥2.86 Billion | CN¥1.34 Billion | ▲ +7.3% |
| 2022 | CN¥1.41 Billion | CN¥2.71 Billion | CN¥1.30 Billion | ▲ +10.4% |
| 2021 | CN¥1.28 Billion | CN¥2.35 Billion | CN¥1.07 Billion | ▲ +8.4% |
| 2020 | CN¥1.18 Billion | CN¥2.05 Billion | CN¥867.05 Million | ▲ +9.0% |
| 2019 | CN¥1.08 Billion | CN¥1.89 Billion | CN¥805.57 Million | ▲ +14.5% |
| 2018 | CN¥946.61 Million | CN¥1.42 Billion | CN¥473.43 Million | ▲ +7.8% |
| 2017 | CN¥878.23 Million | CN¥1.16 Billion | CN¥286.25 Million | ▲ +6.2% |
| 2016 | CN¥827.25 Million | CN¥1.07 Billion | CN¥239.03 Million | ▲ +6.8% |
| 2015 | CN¥774.88 Million | CN¥1.00 Billion | CN¥225.66 Million | ▲ +78.4% |
| 2014 | CN¥434.25 Million | CN¥658.96 Million | CN¥224.71 Million | ▲ +8.0% |
| 2013 | CN¥402.11 Million | CN¥649.48 Million | CN¥247.36 Million | ▲ +14.8% |
| 2012 | CN¥350.42 Million | CN¥443.21 Million | CN¥92.79 Million | ▲ +7.0% |
| 2011 | CN¥327.61 Million | CN¥418.52 Million | CN¥90.91 Million | ▲ +6.0% |
| 2010 | CN¥308.95 Million | CN¥401.08 Million | CN¥92.13 Million | ▲ +5.1% |
| 2009 | CN¥293.89 Million | CN¥383.36 Million | CN¥89.47 Million | ▲ +4.3% |
| 2008 | CN¥281.68 Million | CN¥359.66 Million | CN¥77.98 Million | ▲ +4.3% |
| 2007 | CN¥269.97 Million | CN¥357.66 Million | CN¥87.69 Million | ▲ +4.2% |
| 2006 | CN¥259.20 Million | CN¥335.84 Million | CN¥76.64 Million | ▲ +1.3% |
| 2005 | CN¥255.97 Million | CN¥305.41 Million | CN¥49.44 Million | ▲ +2.2% |
| 2004 | CN¥250.42 Million | CN¥312.05 Million | CN¥61.63 Million | ▲ +1.7% |
| 2003 | CN¥246.22 Million | CN¥293.21 Million | CN¥46.99 Million | ▲ +188.8% |
| 2002 | CN¥85.26 Million | CN¥126.28 Million | CN¥41.02 Million | ▲ +22.7% |
| 2001 | CN¥69.48 Million | CN¥115.66 Million | CN¥46.18 Million | ▲ +26.0% |
| 2000 | CN¥55.16 Million | CN¥103.67 Million | CN¥48.51 Million | — |